Medrad has introduced a new injection system for delivering contrastmedia during CT procedures. The Pittsburgh company's EnVisionCTTM product is smaller and more compact than previous injectionsystems and features touch-screen monitor control,
Medrad has introduced a new injection system for delivering contrastmedia during CT procedures. The Pittsburgh company's EnVisionCTTM product is smaller and more compact than previous injectionsystems and features touch-screen monitor control, front-loadsyringe engagement and automatic syringe filling. Medrad has receivedFood and Drug Administration clearance for the product.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.